MARATTO

article · RSC Advances

Coumarin–amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition

Abstract

value of 0.251 ± 0.011 μM. Finally, the binding mode of the chemical inhibitors at the active site of CK2 receptor was also investigated using a docking study which confirmed that the presence of the amino acid functionality is an important feature for anticancer activity and the synthesized compounds showed favorable ADME properties. Besides that, SAR analysis was implemented for the target compounds.

Research topics

  • Chemical Synthesis and Analysis
  • Cancer therapeutics and mechanisms
  • Phosphodiesterase function and regulation

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1039/d4ra04226c

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.